U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2015
472
Substance Class Protein
Created
by admin
on Mon Mar 31 22:42:45 GMT 2025
Edited
by admin
on Mon Mar 31 22:42:45 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin MOUSE CHIMERIC
Sequence Type COMPLETE
Record UNII
7SQY4ZUD30
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
DINUTUXIMAB
DASH   INN   USAN   WHO-DD  
USAN   INN  
Official Name English
UNITUXIN
Preferred Name English
dinutuximab [INN]
Common Name English
CH14.18-UTC
Code English
CH14.18
Code English
DINUTUXIMAB [PURPLE BOOK CDER]
Common Name English
CHIMERIC ANTI-DISIALOGANGLIOSIDE (GD2) MONOCLONAL ANTIBODY (CH14.18/CHO)
Common Name English
CH-14.18
Code English
APN-311
Code English
CH-1418
Code English
DINUTUXIMAB [JAN]
Common Name English
DINUTUXIMAB [MI]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(GANGLIOSIDE GD2) (HUMAN-MUS MUSCULUS MONOCLONAL CH14.18 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CH14.18 LIGHT CHAIN, DIMER
Common Name English
DINUTUXIMAB [USAN]
Common Name English
CH1418
Code English
CH-14.18-UTC
Code English
Dinutuximab [WHO-DD]
Common Name English
APN311
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 377712
Created by admin on Mon Mar 31 22:42:45 GMT 2025 , Edited by admin on Mon Mar 31 22:42:45 GMT 2025
NCI_THESAURUS C155653
Created by admin on Mon Mar 31 22:42:45 GMT 2025 , Edited by admin on Mon Mar 31 22:42:45 GMT 2025
FDA ORPHAN DRUG 324210
Created by admin on Mon Mar 31 22:42:45 GMT 2025 , Edited by admin on Mon Mar 31 22:42:45 GMT 2025
EMA ASSESSMENT REPORTS UNITUXIN (AUTHORIZTION: NEUROBLASTOMA)
Created by admin on Mon Mar 31 22:42:45 GMT 2025 , Edited by admin on Mon Mar 31 22:42:45 GMT 2025
NCI_THESAURUS C129822
Created by admin on Mon Mar 31 22:42:45 GMT 2025 , Edited by admin on Mon Mar 31 22:42:45 GMT 2025
NDF-RT N0000191500
Created by admin on Mon Mar 31 22:42:45 GMT 2025 , Edited by admin on Mon Mar 31 22:42:45 GMT 2025
WHO-ATC L01XC16
Created by admin on Mon Mar 31 22:42:45 GMT 2025 , Edited by admin on Mon Mar 31 22:42:45 GMT 2025
Code System Code Type Description
CAS
1613303-02-8
Created by admin on Mon Mar 31 22:42:45 GMT 2025 , Edited by admin on Mon Mar 31 22:42:45 GMT 2025
ALTERNATIVE
MERCK INDEX
m11838
Created by admin on Mon Mar 31 22:42:45 GMT 2025 , Edited by admin on Mon Mar 31 22:42:45 GMT 2025
PRIMARY
CHEMBL
CHEMBL2109420
Created by admin on Mon Mar 31 22:42:45 GMT 2025 , Edited by admin on Mon Mar 31 22:42:45 GMT 2025
PRIMARY
DRUG BANK
DB09077
Created by admin on Mon Mar 31 22:42:45 GMT 2025 , Edited by admin on Mon Mar 31 22:42:45 GMT 2025
PRIMARY
RXCUI
1606274
Created by admin on Mon Mar 31 22:42:45 GMT 2025 , Edited by admin on Mon Mar 31 22:42:45 GMT 2025
PRIMARY RxNorm
FDA UNII
7SQY4ZUD30
Created by admin on Mon Mar 31 22:42:45 GMT 2025 , Edited by admin on Mon Mar 31 22:42:45 GMT 2025
PRIMARY
WIKIPEDIA
Dinutuximab
Created by admin on Mon Mar 31 22:42:45 GMT 2025 , Edited by admin on Mon Mar 31 22:42:45 GMT 2025
PRIMARY
LACTMED
Dinutuximab
Created by admin on Mon Mar 31 22:42:45 GMT 2025 , Edited by admin on Mon Mar 31 22:42:45 GMT 2025
PRIMARY
DRUG CENTRAL
4948
Created by admin on Mon Mar 31 22:42:45 GMT 2025 , Edited by admin on Mon Mar 31 22:42:45 GMT 2025
PRIMARY
CAS
1363687-32-4
Created by admin on Mon Mar 31 22:42:45 GMT 2025 , Edited by admin on Mon Mar 31 22:42:45 GMT 2025
PRIMARY
NDF-RT
N0000191499
Created by admin on Mon Mar 31 22:42:45 GMT 2025 , Edited by admin on Mon Mar 31 22:42:45 GMT 2025
PRIMARY Glycolipid Disialoganglioside-directed Antibody Interactions [MoA]
SMS_ID
100000156453
Created by admin on Mon Mar 31 22:42:45 GMT 2025 , Edited by admin on Mon Mar 31 22:42:45 GMT 2025
PRIMARY
EVMPD
SUB130362
Created by admin on Mon Mar 31 22:42:45 GMT 2025 , Edited by admin on Mon Mar 31 22:42:45 GMT 2025
PRIMARY
ChEMBL
CHEMBL3137342
Created by admin on Mon Mar 31 22:42:45 GMT 2025 , Edited by admin on Mon Mar 31 22:42:45 GMT 2025
PRIMARY
IUPHAR
7979
Created by admin on Mon Mar 31 22:42:45 GMT 2025 , Edited by admin on Mon Mar 31 22:42:45 GMT 2025
PRIMARY
INN
9754
Created by admin on Mon Mar 31 22:42:45 GMT 2025 , Edited by admin on Mon Mar 31 22:42:45 GMT 2025
PRIMARY
NCI_THESAURUS
C1570
Created by admin on Mon Mar 31 22:42:45 GMT 2025 , Edited by admin on Mon Mar 31 22:42:45 GMT 2025
PRIMARY
DAILYMED
7SQY4ZUD30
Created by admin on Mon Mar 31 22:42:45 GMT 2025 , Edited by admin on Mon Mar 31 22:42:45 GMT 2025
PRIMARY
USAN
AB-125
Created by admin on Mon Mar 31 22:42:45 GMT 2025 , Edited by admin on Mon Mar 31 22:42:45 GMT 2025
PRIMARY
From To
1_22 1_96
1_140 1_196
1_257 1_317
1_363 1_421
2_22 2_96
2_140 2_196
2_257 2_317
2_363 2_421
3_23 3_93
3_140 3_200
4_23 4_93
4_140 4_200
1_216 3_220
2_216 4_220
1_222 2_222
1_225 2_225
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_293
N 2_293
Related Record Type Details
Structure of DISIALOGANGLIOSIDE GD-2
TARGET->LIGAND
DINUTUXIMAB BETA
SUB_CONCEPT->SUBSTANCE
Related Record Type Details
DINUTUXIMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966